“treatment resistant depression”的搜索结果，显示 111-120 项，共有 2751 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the effectiveness and safety of tazemetostat in combination with R2 in subjects with Relapsed/Refractory Follicular ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the effectiveness and safety of tazemetostat in combination with R2 in subjects with Relapsed/Refractory Follicular ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery. Scottsdale/Phoenix, Ariz., ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the effectiveness and safety of tazemetostat in combination with R2 in subjects with Relapsed/Refractory Follicular ...

5. 泌尿科- 临床试验- 妙佑医疗国际

   The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult patients with Relapsed or Refractory NHL. The trial will be ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... treating patients with B-cell non-Hodgkin lymphoma that has returned (recurrent) or did not respond to treatment (refractory). Monoclonal antibodies, such ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or CCUS. Rochester, Minn., Mankato, Minn., La Crosse, Wis., Eau ...

9. Mayo Clinic Pulmonology Physician Update - December 2024

   Page 1.

10. Mayo Clinic Neurosciences Physician Update — January 2025

    Page 1.